Clinical Trials Browser

Phase 3 × Prostatic Neoplasms, Castration-Resistant × 30 days × Clear all

NCT07225946 2026-05-11

KLK2-PASenger

Phase 3 Recruiting

Prostatic Neoplasms, Castration-Resistant

NCT03748641 2026-05-08

MAGNITUDE

Phase 3 Active not recruiting

765 enrolled 16 charts 1 FDA

Prostatic Neoplasms, Castration-Resistant